Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

"European price controls and austerity measures reduce the attractiveness of its markets," Novartis CEO Vas Narasimhan and ...

The first-quarter 2025 earnings season for the Medical sector is about to pick up pace this week. The sector mainly comprises ...

Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Irish pharmaceutical and medical product exports to the US rose by more than 450% year-on-year in February, the second ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

1542 ET – Bond markets send grim signals as Treasury yields rise almost every day of the week, even as equity markets plunged. The unusual combination has been attributed to foreign investors ...